NasdaqGS:ACLXBiotechs
Is It Too Late To Consider Arcellx (ACLX) After Its Strong 81% YTD Rally?
Wondering if Arcellx at around US$114 per share still offers value, or if the easy money has already been made.
The stock has YTD returns of 81.0% and a 1 year return of 68.7%, although the past week has been flat at around a 0.1% decline and the 30 day move sits at 0.8%.
Recent coverage has focused on Arcellx as a higher growth biotech name, which helps explain why the share price has been so strong over the past year. That kind of attention often shifts how investors think about both the...